Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP)

Clinical and Experimental Metastasis · Published 2026-07-30 · DOI 10.1007/s10585-026-10417-x

Free full text

Authors (8)

Hanxiao Chen, Xiangjiao Meng, Ling Cai, Wei Lei, Yu Tang, Xi Shi, Leilei Ma, Jun Zhao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, H., Meng, X., Cai, L., et al. (2026). Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP). Clinical and Experimental Metastasis. https://doi.org/10.1007/s10585-026-10417-x

Related articles

• Impact of neoadjuvant cetuximab on liver function and tumor reduction in a murine model of selective portal vein ligation · Clinical and Experimental Metastasis · 2025 · Same journal
• The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery · Clinical and Experimental Metastasis · 2025 · Same journal
• Gamma knife radiosurgery for cerebellar brain metastases: clinical outcomes and artificial intelligence-based predictive modeling · Clinical and Experimental Metastasis · 2026 · Same journal
• Importance of the timing of combined electrochemotherapy and immunotherapy in the treatment of advanced melanoma · Clinical and Experimental Metastasis · 2025 · Same journal
• FOXM1 expression is induced by the brain microenvironment and supports CRC brain metastatic adaptation · Clinical and Experimental Metastasis · 2026 · Same journal
• CYP4B1 inhibits lung adenocarcinoma metastasis by downregulating slug transcription via Sp1 · Clinical and Experimental Metastasis · 2026 · Same journal
• Prognostic influence of chronic inflammation in patients with head and neck cancer based on sex differences · Clinical and Experimental Metastasis · 2025 · Same journal
• Contribution of tumor-derived extracellular vesicles in the establishment of the pre-metastatic niche: lessons learned from past experimentations and future directions · Clinical and Experimental Metastasis · 2026 · Same journal
• Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma · Clinical and Experimental Metastasis · 2025 · Same journal
• Encapsulated histopathological growth pattern of colorectal liver metastases predicts prolonged survival after repeat liver resection for recurrence · Clinical and Experimental Metastasis · 2026 · Same journal